CASP9 and melanoma: As a result of the combination treatment, Bcl-2, an anti-apoptotic protein, decreased in both melanoma cell lines, while a significant increase was observed in pro-apoptotic Bax and pro-apoptotic caspase-9 and caspase-3 protein levels.